DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -52.3% | -32% | 33.4% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -2.9% | 18% | 26.6% | 34.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3 | -$3 | -$3 | -$3 |
| Operating Expenses | -$2 | -$1 | -$1 | -$2 |
| Operating Income | $2 | $1 | $1 | $2 |
| % Margin | 730.6% | 305.3% | 206.2% | 331.3% |
| Other Income/Exp. Net | -$2 | -$1 | -$1 | -$2 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | $3 | -$4 |
| % Margin | -826.7% | -355.8% | 412% | -734.5% |
| EPS | -0.003 | -0.003 | 0.01 | -0.009 |
| % Growth | 0% | -130% | 211.1% | – |
| EPS Diluted | -0.003 | -0.003 | 0.01 | -0.009 |
| Weighted Avg Shares Out | 630 | 564 | 496 | 430 |
| Weighted Avg Shares Out Dil | 630 | 564 | 496 | 430 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -662.2% | -267.8% | -144.7% | -246.6% |